The Systemic Inflammation Score is Associated with the Survival of Patients with Prostate Cancer

References

• Rebello RJ, Oing C, Knudsen KE, et al. Prostate cancer. Nat Rev Dis Primers. 2021;7(1):9. doi:10.1038/s41572-020-00243-0
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J. Erratum: global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2020;70(4):313. doi:10.3322/caac.21609
   Web of Science ®Google Scholar
• Lomas DJ, Ahmed HU. All change in the prostate cancer diagnostic pathway. Nat Rev Clin Oncol. 2020;17(6):372–381. doi:10.1038/s41571-020-0332-z
   Web of Science ®Google Scholar
• Sandhu S, Moore CM, Chiong E, Beltran H, Bristow RG, Williams SG. Prostate cancer. Lancet. 2021;398(10305):1075–1090. doi:10.1016/S0140-6736(21)
   PubMed Web of Science ®Google Scholar
• Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. 2018;392(10159):2052–2090. doi:10.1016/S0140-6736(18)31694-5
   PubMed Web of Science ®Google Scholar
• Disease GBD, Injury I, Prevalence C. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–1858. doi:10.1016/S0140-6736(18)32279-7
   PubMed Web of Science ®Google Scholar
• Carneiro A, Baccaglini W, Glina FPA, et al. Impact of local treatment on overall survival of patients with metastatic prostate cancer: systematic review and meta-analysis. Int Braz J Urol. 2017;43(4):588–599. doi:10.1590/S1677-5538.IBJU.2016.0483
   PubMed Web of Science ®Google Scholar
• Greten FR, Grivennikov SI. Inflammation and Cancer: triggers, Mechanisms, and Consequences. Immunity. 2019;51(1):27–41. doi:10.1016/j.immuni.2019.06.025
   PubMed Web of Science ®Google Scholar
• Todoric J, Karin M. The Fire within: cell-Autonomous Mechanisms in Inflammation-Driven Cancer. Cancer Cell. 2019;35(5):714–720. doi:10.1016/j.ccell.2019.04.001
   PubMed Web of Science ®Google Scholar
• Hou J, Karin M, Sun B. Targeting cancer-promoting inflammation - have anti-inflammatory therapies come of age? Nat Rev Clin Oncol. 2021;18(5):261–279. doi:10.1038/s41571-020-00459-9
   PubMed Web of Science ®Google Scholar
• Koliaraki V, Prados A, Armaka M, Kollias G. The mesenchymal context in inflammation, immunity and cancer. Nat Immunol. 2020;21(9):974–982. doi:10.1038/s41590-020-0741-2
   PubMed Web of Science ®Google Scholar
• Tokumaru Y, Oshi M, Murthy V, et al. Low intratumoral genetic neutrophil-to-lymphocyte ratio (NLR) is associated with favorable tumor immune microenvironment and with survival in triple negative breast cancer (TNBC). Am J Cancer Res. 2021;11(11):5743–5755.
   PubMed Web of Science ®Google Scholar
• Chen C, Yang H, Cai D, Xiang L, Fang W, Wang R. Preoperative peripheral blood neutrophil-to-lymphocyte ratios (NLR) and platelet-to-lymphocyte ratio (PLR) related nomograms predict the survival of patients with limited-stage small-cell lung cancer. Transl Lung Cancer Res. 2021;10(2):866–877. doi:10.21037/tlcr-20-997
   Web of Science ®Google Scholar
• Mandaliya H, Jones M, Oldmeadow C, Nordman II. Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI). Transl Lung Cancer Res. 2019;8(6):886–894. doi:10.21037/tlcr.2019.11.16
   PubMed Web of Science ®Google Scholar
• Peng RR, Liang ZG, Chen KH, Li L, Qu S, Zhu XD. Nomogram Based on Lactate Dehydrogenase-to-Albumin Ratio (LAR) and Platelet-to-Lymphocyte Ratio (PLR) for Predicting Survival in Nasopharyngeal Carcinoma. J Inflamm Res. 2021;14:4019–4033. doi:10.2147/JIR.S322475
   PubMed Web of Science ®Google Scholar
• Gupta V, Chaudhari V, Shrikhande SV, Bhandare MS. Does Preoperative Serum Neutrophil to Lymphocyte Ratio (NLR), Platelet to Lymphocyte Ratio (PLR), and Lymphocyte to Monocyte Ratio (LMR) Predict Prognosis Following Radical Surgery for Pancreatic Adenocarcinomas? Results of a Retrospective Study. J Gastrointest Cancer. 2021. doi:10.1007/s12029-021-00683-1
   Web of Science ®Google Scholar
• Guo Y, Wei L, Patel SH, et al. Serum Albumin: early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy. Clin Lung Cancer. 2022. doi:10.1016/j.cllc.2021.12.010
   Web of Science ®Google Scholar
• Leibowitz-Amit R, Israel A, Gal M, et al. Association between the Absolute Baseline Lymphocyte Count and Response to Neoadjuvant Platinum-based Chemotherapy in Muscle-invasive Bladder Cancer. Clin Oncol. 2016;28(12):790–796. doi:10.1016/j.clon.2016.07.007
   Web of Science ®Google Scholar
• Chang Y, An H, Xu L, et al. Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma. Br J Cancer. 2015;113(4):626–633. doi:10.1038/bjc.2015.241
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Pietrocola F, Kroemer G. Nutrition, inflammation and cancer. Nat Immunol. 2017;18(8):843–850. doi:10.1038/ni.3754
   PubMed Web of Science ®Google Scholar
• Crusz SM, Balkwill FR. Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol. 2015;12(10):584–596. doi:10.1038/nrclinonc.2015.105
   PubMed Web of Science ®Google Scholar
• Marazzi I, Greenbaum BD, Low DHP, Guccione E. Chromatin dependencies in cancer and inflammation. Nat Rev Mol Cell Biol. 2018;19(4):245–261. doi:10.1038/nrm.2017.113
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Okabayashi K, Hasegawa H, et al. Comparison of Preoperative Inflammation-based Prognostic Scores in Patients With Colorectal Cancer. Ann Surg. 2018;267(3):527–531. doi:10.1097/SLA.0000000000002115
   PubMed Web of Science ®Google Scholar
• Feng Y, Liu L, Zhu Y. Systemic inflammation score in locally advanced rectal cancer patients following total mesorectal excision. Onco Targets Ther. 2019;12:6617–6622. doi:10.2147/OTT.S213720
   PubMed Web of Science ®Google Scholar
• Wang F, He W, Jiang C, et al. Prognostic value of inflammation-based scores in patients receiving radical resection for colorectal cancer. BMC Cancer. 2018;18(1):1102. doi:10.1186/s12885-018-4842-3
   Google Scholar
• Martinez-Lago N, Fernandez-Montes A, Covela M, et al. Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain. BMC Cancer. 2021;21(1):64. doi:10.1186/s12885-020-07758-5
   Web of Science ®Google Scholar
• Galizia G, Lieto E, Auricchio A, et al. Naples Prognostic Score, Based on Nutritional and Inflammatory Status, is an Independent Predictor of Long-term Outcome in Patients Undergoing Surgery for Colorectal Cancer. Dis Colon Rectum. 2017;60(12):1273–1284. doi:10.1097/DCR.0000000000000961
   PubMed Web of Science ®Google Scholar
• Sato B, Kanda M, Tanaka C, et al. Significance of Preoperative Systemic Inflammation Score in Short-Term and Long-Term Outcomes of Patients with Pathological T2-4 Gastric Cancer After Radical Gastrectomy. World J Surg. 2018;42(10):3277–3285. doi:10.1007/s00268-018-4597-7
   PubMed Web of Science ®Google Scholar
• Lin JX, Lin JP, Xie JW, et al. Prognostic importance of the preoperative modified systemic inflammation score for patients with gastric cancer. Gastric Cancer. 2019;22(2):403–412. doi:10.1007/s10120-018-0854-6
   PubMed Web of Science ®Google Scholar
• Ma M, Weng M, Chen F, et al. Systemic inflammation score is a prognostic marker after curative resection in gastric cancer. ANZ J Surg. 2019;89(4):377–382. doi:10.1111/ans.15103
   PubMed Web of Science ®Google Scholar
• Hara K, Aoyama T, Yamada T, et al. The Prognostic Value of the Perioperative Systemic Inflammation Score for Patients With Advanced Gastric Cancer. Anticancer Res. 2020;40(3):1503–1512. doi:10.21873/anticanres.14095
   PubMed Web of Science ®Google Scholar
• Chen YR, Chen YL, Ouyang SS, et al. Prognostic efficacy of preoperative mGPS, SIS and LCS in patients with gastric cancer. Clin Chim Acta. 2020;511:81–89. doi:10.1016/j.cca.2020.09.027
   Web of Science ®Google Scholar
• Lin JX, Huang YQ, Wang ZK, et al. Prognostic importance of dynamic changes in systemic inflammatory markers for patients with gastric cancer. J Surg Oncol. 2021;124(3):282–292. doi:10.1002/jso.26498
   Web of Science ®Google Scholar
• Inagaki K, Kanda M, Nakanishi K, et al. Accurate Prediction of Prognosis After Radical Resection of Gastric Cancer by the Modified Systemic Inflammation Score; a Multicenter Dataset Analysis. World J Surg. 2021;45(8):2513–2520. doi:10.1007/s00268-021-06138-9
   Web of Science ®Google Scholar
• Li S, Zhang W, Yang Z, Li Y, Du H, Che G. Systemic Inflammation Score as a Novel Prognostic Indicator for Patients Undergoing Video-Assisted Thoracoscopic Surgery Lobectomy for Non-Small-Cell Lung Cancer. J Invest Surg. 2021;34(4):428–440. doi:10.1080/08941939.2019.1641169
   PubMed Web of Science ®Google Scholar
• Markus M, Abendroth A, Noureddine R, et al. Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy. J Cancer Res Clin Oncol. 2021;147(2):579–591. doi:10.1007/s00432-020-03361-0
   Web of Science ®Google Scholar
• Xu M, Wu Q, Cai L, Sun X, Xie X, Sun P. Systemic Inflammatory Score predicts Overall Survival in patients with Cervical Cancer. J Cancer. 2021;12(12):3671–3677. doi:10.7150/jca.56170
   PubMed Web of Science ®Google Scholar
• Huang ZZ, Hua X, Song CG, et al. The Prognostic Prediction Value of Systemic Inflammation Score and the Development of a Nomogram for Patients With Surgically Treated Breast Cancer. Front Oncol. 2020;10:563731. doi:10.3389/fonc.2020.563731
   PubMed Web of Science ®Google Scholar
• Buigues C, Navarro-Martinez R, Sanchez-Martinez V, Serrano-Carrascosa M, Rubio-Briones J, Cauli O. Interleukin-6 and Lymphocyte Count Associated and Predicted the Progression of Frailty Syndrome in Prostate Cancer Patients Undergoing Antiandrogen Therapy. Cancers. 2020;12:7. doi:10.3390/cancers12071716
   Web of Science ®Google Scholar
• Guo Y, Shi D, Zhang J, et al. The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score is a Novel Significant Prognostic Factor for Patients with Metastatic Prostate Cancer Undergoing Cytoreductive Radical Prostatectomy. J Cancer. 2019;10(1):81–91. doi:10.7150/jca.27210
   PubMed Web of Science ®Google Scholar
• Yang ZR, Zhao N, Meng J, et al. Peripheral lymphocyte subset variation predicts prostate cancer carbon ion radiotherapy outcomes. Oncotarget. 2016;7(18):26422–26435. doi:10.18632/oncotarget.8389
   PubMedGoogle Scholar
• Roviello G, Nardone V, Bonetta A, et al. Effects of Whole Pelvic Radiotherapy on the Distribution of Lymphocyte Subpopulations in Prostate Cancer Patients. Am J Clin Oncol. 2022;45(3):105–111. doi:10.1097/COC.0000000000000894
   Web of Science ®Google Scholar
• Xu X, Wang D, Chen W, et al. A nomogram model based on peripheral blood lymphocyte subsets to assess the prognosis of non-small cell lung cancer patients treated with immune checkpoint inhibitors. Transl Lung Cancer Res. 2021;10(12):4511–4525. doi:10.21037/tlcr-21-899
   Web of Science ®Google Scholar
• Lee YJ, Park YS, Lee HW, Park TY, Lee JK, Heo EY. Peripheral lymphocyte count as a surrogate marker of immune checkpoint inhibitor therapy outcomes in patients with non-small-cell lung cancer. Sci Rep. 2022;12(1):626. doi:10.1038/s41598-021-04630-9
   PubMed Web of Science ®Google Scholar
• Olingy CE, Dinh HQ, Hedrick CC. Monocyte heterogeneity and functions in cancer. J Leukoc Biol. 2019;106(2):309–322. doi:10.1002/JLB.4RI0818-311R
   PubMed Web of Science ®Google Scholar
• Raposo TP, Pires I, Carvalho MI, Prada J, Argyle DJ, Queiroga FL. Tumour-associated macrophages are associated with vascular endothelial growth factor expression in canine mammary tumours. Vet Comp Oncol. 2015;13(4):464–474. doi:10.1111/vco.12067
   Web of Science ®Google Scholar
• Yasui K, Shida D, Nakamura Y, Ahiko Y, Tsukamoto S, Kanemitsu Y. Postoperative, but not preoperative, inflammation-based prognostic markers are prognostic factors in stage III colorectal cancer patients. Br J Cancer. 2021;124(5):933–941. doi:10.1038/s41416-020-01189-6
   PubMed Web of Science ®Google Scholar
• Park JW, Chang HJ, Yeo HY, et al. The relationships between systemic cytokine profiles and inflammatory markers in colorectal cancer and the prognostic significance of these parameters. Br J Cancer. 2020;123(4):610–618. doi:10.1038/s41416-020-0924-5
   PubMed Web of Science ®Google Scholar
• Li Y, Jia H, Yu W, et al. Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection. Int J Cancer. 2016;139(1):220–231. doi:10.1002/ijc.30071
   PubMed Web of Science ®Google Scholar
• Almasaudi AS, Dolan RD, Edwards CA, McMillan DC. Hypoalbuminemia Reflects Nutritional Risk, Body Composition and Systemic Inflammation and Is Independently Associated with Survival in Patients with Colorectal Cancer. Cancers. 2020;12(7). doi:10.3390/cancers12071986
   Web of Science ®Google Scholar
• Nazha B, Moussaly E, Zaarour M, Weerasinghe C, Azab B. Hypoalbuminemia in colorectal cancer prognosis: nutritional marker or inflammatory surrogate? World J Gastrointest Surg. 2015;7(12):370–377. doi:10.4240/wjgs.v7.i12.370
   PubMed Web of Science ®Google Scholar
• Haskins IN, Baginsky M, Amdur RL, Agarwal S. Preoperative hypoalbuminemia is associated with worse outcomes in colon cancer patients. Clin Nutr. 2017;36(5):1333–1338. doi:10.1016/j.clnu.2016.08.023
   PubMed Web of Science ®Google Scholar
• Miyata H, Yamasaki M, Kurokawa Y, et al. Prognostic value of an inflammation-based score in patients undergoing pre-operative chemotherapy followed by surgery for esophageal cancer. Exp Ther Med. 2011;2(5):879–885. doi:10.3892/etm.2011.308
   Web of Science ®Google Scholar
• Watt DG, McSorley ST, Park JH, Horgan PG, McMillan DC, Postoperative Systemic A. Inflammation Score Predicts Short- and Long-Term Outcomes in Patients Undergoing Surgery for Colorectal Cancer. Ann Surg Oncol. 2017;24(4):1100–1109. doi:10.1245/s10434-016-5659-4
   PubMed Web of Science ®Google Scholar